Research theme for competitive and other funds (2):
2024 - 2029 レビー小体病における疾患修飾薬開発に資する画像モニタリング評価基盤の確立
2021 - 2024 進行性核上性麻痺における疾患修飾薬開発に資するモニタリング評価基盤の確立
Papers (65):
Ryoji Goto, Kiwamu Matsuoka, Yasuyuki Kimura, Yuko Kataoka, Masaki Oya, Kosei Hirata, Kenji Tagai, Keisuke Takahata, Chie Seki, Kazunori Kawamura, et al. Human biodistribution and radiation dosimetry of two novel α-synuclein PET tracers, 18F-SPAL-T-06 and 18F-C05-05. Scientific reports. 2025. 15. 1. 8640-8640
Yasuharu Yamamoto, Keisuke Takahata, Morinobu Seki, Shohei Okusa, Harutsugu Tatebe, Ryo Ueda, Hironobu Endo, Kenji Tagai, Sho Moriguchi, Shin Kurose, et al. SLC9A6-Linked Parkinson Syndrome in Female Heterozygotes Is Associated With PET-Detectable Tau Pathology. Neurology. Genetics. 2025. 11. 1. e200235
Hisaomi Suzuki, Kenji Tagai, Maiko Ono, Hiroshi Shimizu, Hironobu Endo, Hideki Matsumoto, Manabu Kubota, Yuko Kataoka, Sho Moriguchi, Shin Kurose, et al. Distinct tau pathologies in the nucleus basalis of Meynert between early-onset and late-onset Alzheimer's disease patients revealed by positron emission tomography. Journal of Alzheimer's disease : JAD. 2024. 13872877241297382-13872877241297382
Yasunori Sano, Yasuharu Yamamoto, Manabu Kubota, Sho Moriguchi, Kiwamu Matsuoka, Shin Kurose, Kenji Tagai, Hironobu Endo, Bun Yamagata, Hisaomi Suzuki, et al. Alterations of striatal phosphodiesterase 10 A and their association with recurrence rate in bipolar I disorder. Translational Psychiatry. 2024
Kenji Tagai, Harutsugu Tatebe, Sayo Matsuura, Zhang Hong, Naomi Kokubo, Kiwamu Matsuoka, Hironobu Endo, Asaka Oyama, Kosei Hirata, Hitoshi Shinotoh, et al. A novel plasma p-tau181 assay as a specific biomarker of tau pathology in Alzheimer's disease. Translational neurodegeneration. 2024. 13. 1. 44-44
In vivo evaluation of tau pathologies in patient with PSP and healthy subjects with [11C]PBB3-PET.
(20th International congress of parkinson’s disease and movement disorders 2016)